申请人:CALLAGHAN INNOVATION RES LTD
公开号:WO2014017928A1
公开(公告)日:2014-01-30
This invention relates to sphingoglycolipid analogues, compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer.
本发明涉及鞘氨醇糖脂类似物,包括这些化合物的组合物,制备这些化合物的方法,以及使用这些化合物治疗或预防疾病或病况的方法,如与感染、特应性障碍、自身免疫疾病、糖尿病或癌症相关的疾病或病况。